Bessent Says No, But Maybe Later, to Fresh Bitcoin Buying
Olga Kharif writes on how Treasury Secretary Scott Bessent is straddling a fine line when it comes to the US acquiring Bitcoin for its cryptocurrency strategic reserve.
The dream was never confirmed. But it was never denied either.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
It's time to put these three crypto IPOs on your radar after Circle and Bullish's big debuts
It's time to put these three crypto IPOs on your radar after Circle and Bullish's big debuts originally appeared on TheStreet. Whether or not you think crypto is a pivotal technology or generational scam, there's no arguing that there's money to be made off of it. But despite the improbable returns and all-time highs in leading digital assets like Bitcoin and Ethereum, there might arguably be even better money for investors buying companies selling access to the boom. See, there's an old adage about selling pickaxes to gold miners. And arguably, nobody's done it better than Robinhood () and Coinbase () . The two industry leaders spent years in the dumps after their respective 2021 IPOs, but with the years-long recession of trading speculation in the rear view, the two companies have soared. They're up 475% and 62% over the last year. Their performances have created a lot of FOMO among crypto and fintech operators. And thanks to a slew of new pro-crypto policies from the Republican-run U.S. government, and record valuations in digital asset land, there's a new boom of firms seeking out Wall Street. It's already created some of the year's most fantastical rallies. Take USDC creator Circle Technology () for example, it's up over 400% since its IPO. It's not a one-off thing, either: crypto exchange and media firm Bullish BLSH, which IPOed this past week, proved the demand for crypto IPOs is durable; it's nearly doubled from its IPO price. So who should be on your radar next? Here are three to watch out for: Grayscale If not for Grayscale, the largest digital asset manager, we might have been waiting years for Bitcoin and Ethereum ETFs to become reality. The company was a first-mover in bringing crypto to Wall Street through its Grayscale Bitcoin Trust and Grayscale Ethereum Trust. The funds, plus dozens of other products offered by the asset manager, offered spot exposure to the digital assets long before major asset managers paid any mind to the crypto industry. Next on its list, it plans to take itself to Wall Street, capitalizing on the robust drip of management fees from its various crypto products. It manages over $33 billion in assets. In mid-July, it was reported that the firm had confidentially filed for an IPO. Gemini They might not have invented Facebook, but settlement money in hand, the Winklevoss twins have managed to build a billion-dollar business in the burgeoning crypto business. After buying millions in Bitcoin and attempting to bring a 'Winklevoss Bitcoin Fund' to Wall Street over a decade ago, the twins settled for building their own crypto exchange. Today, Gemini has grown to be one of the larger centralized exchanges. As a result, it's seeking to strike while crypto demand is strong. In fact, it was one of the first firms to throw its hat in the ring, in light of the strong performance seen by Circle. Last it raised money from venture capital investors in Nov. 2021, crypto was at all-time highs. Filing confidentially for an IPO, the company would likely seek a valuation around the $7.1 billion it fetched back then. BitGo Crypto custodian BitGo has also joined the chorus of crypto firms seeking a home on Wall Street. It might score big, given the fact that it's already a massive home for crypto assets. BitGo custodies over $100 billion in assets now, making it one of the largest holders of crypto. It provides services directly to exchanges, asset managers, and other businesses. Not just holding and securing coins, but staking them and providing trading, lending, and borrowing services as a prime broker. It's fair to assume that the firm's near-doubling in assets over the last year is an indication it's ready for prime time, but outside of the $1.75 billion valuation it fetched in Aug. 2023, we won't know a whole lot more until the company's confidential IPO becomes public. Are crypto IPOs a safe bet? It's hard to call anything a sure thing these days, particularly with U.S. stock benchmarks and crypto markets at record levels. For those interested in playing the IPOs, there's likely an opportunity to hop in on the ground floor of the new listings, playing the first-day pop and ensuing optimism. Some brokerages, like Robinhood and SoFi, even allow investors to request shares at the IPO price. For longer-term holders, closer examination of the companies' financials will be a must. Most of that information is not public yet, though. To that end, if you're a crypto believer, a bet on these firms might make sense if they're financially strong and growing. But given the nature of this fickle market, that means betting that the crypto market's best days are still ahead. And that's by no means a sure thing. It's time to put these three crypto IPOs on your radar after Circle and Bullish's big debuts first appeared on TheStreet on Aug 16, 2025 This story was originally reported by TheStreet on Aug 16, 2025, where it first appeared. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21 minutes ago
- Yahoo
AstraZeneca (LSE:AZN) Launches FluMist Home For At-Home Influenza Vaccination
AstraZeneca recently launched "FluMist Home," an at-home flu vaccine delivery service, marking an important milestone for easier access to vaccinations in 34 U.S. states. This initiative likely contributed to its stock price increase of 12% last quarter, as it aligns with AstraZeneca's push towards innovative healthcare solutions. Despite this positive development, the overall market also experienced an upward trend, with the Dow hitting record highs and the market up 1% over the last week. AstraZeneca's performance seems to have been buoyed by both its strategic product launches and the broader market gains. Every company has risks, and we've spotted 2 possible red flags for AstraZeneca you should know about. The end of cancer? These 26 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's. The launch of AstraZeneca's "FluMist Home" aligns well with the company's focus on innovative healthcare solutions, potentially impacting the narrative around its future growth. This new service might enhance revenue streams by tapping into the demand for convenient medical solutions. Over the last five years, AstraZeneca's total shareholder returns, including both share price and dividends, have risen by 54.08%. This growth provides a broader context to the company's performance, indicating resilience and strong returns for investors. Over the past year, AstraZeneca's share price movement has been in line with the performance of the UK Pharmaceuticals industry, which returned 10.3%. Looking at the potential impact on revenue and earnings forecasts, the initiative could bolster AstraZeneca's earnings as analysts anticipate a growth to $13.9 billion by 2028, up from $8.3 billion today. The recent stock price increase narrows the gap to the consensus analyst price target of £137.89, reflecting a potential 18.95% discount from the current share price of £115.92. This price movement suggests optimism among investors regarding the company's ability to meet future expectations. Our comprehensive valuation report raises the possibility that AstraZeneca is priced lower than what may be justified by its financials. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include LSE:AZN. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21 minutes ago
- Yahoo
Joby Aviation (JOBY) Achieves Historic eVTOL Flight Between Public Airports in FAA-Controlled Airspace
Joby Aviation recently marked a landmark moment with its successful piloted eVTOL flight between two U.S. airports, reinforcing its readiness for commercial operations. This achievement, alongside its progress in preparing for FAA certification and strategic partnerships, has likely influenced the company's 125% share price rise over the past quarter. Despite Joby's ongoing financial losses reported in its latest earnings, the broader market trend of investor optimism and anticipation of future Federal Reserve actions, along with the Dow Jones hitting all-time highs, may have also played into the increased investor interest and confidence in Joby's potential growth trajectory. We've identified 4 weaknesses for Joby Aviation (1 shouldn't be ignored) that you should be aware of. We've found 19 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. Over the past year, Joby Aviation's total shareholder return was 222.91%, reflecting a substantial gain against the backdrop of its ongoing developments and strategic ventures. This impressive performance has significantly outpaced the US Airlines industry return of 70.8% and the broader US market return of 17.1% over the same period. Such momentum underscores the growing investor confidence in Joby's future prospects despite its current financial challenges. The recent advancements, including the successful eVTOL flight, have likely contributed to positive revenue and earnings expectations. However, the company remains unprofitable and is forecast to continue incurring losses in the near term. The current share price of US$16.63 surpasses the consensus analyst price target of US$10.83, indicating potential market exuberance or confidence beyond what analysts currently project. Explore Joby Aviation's analyst forecasts in our growth report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include JOBY. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
